Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00347 | lncRNA-ITGA2 gRNA5-gRNA6 KO plasmid | lncRNA-ITGA2 | $850 | |||
GP01036 | lncRNA-ITGA2 gRNA1-gRNA2 KO plasmid | lncRNA-ITGA2 | $850 | |||
KO00692 | lncRNA-ITGA2 Knockout cell line(293T) | Human | lncRNA-ITGA2 | 1:3~1:6 | Negative | Online Inquiry |
lncRNA-ITGA2 Gene Knockout Cell Lines are genetically engineered cell lines specifically created to lack the expression of long non-coding RNA (lncRNA) associated with integrin alpha-2 (ITGA2). These cell lines serve as critical tools for the study of gene function and regulation, providing insights into the biological roles of lncRNAs in various cellular processes, including cell adhesion, migration, and proliferation. The absence of lncRNA-ITGA2 enables researchers to investigate the downstream effects of ITGA2 signaling pathways and their implications in health and disease.
The key functions of these knockout cell lines hinge upon their ability to modulate cellular responses. By disrupting the lncRNA-ITGA2 expression, these cell lines facilitate the analysis of integrin-mediated signaling cascades, allowing scientists to explore how these pathways contribute to physiological functions and pathophysiological conditions such as cancer metastasis or fibrosis. Additionally, the knockout of lncRNA-ITGA2 provides a unique model to delineate interactions between lncRNA and mRNA, enhancing our understanding of gene regulatory networks.
Scientifically significant, lncRNA-ITGA2 Gene Knockout Cell Lines find applications in both basic research and clinical settings. They serve as invaluable resources for dissecting the molecular mechanisms underlying integrin-related diseases, aiding in the identification of novel therapeutic targets. Furthermore, these cell lines are suitable for high-throughput screening in drug discovery processes, where their responsiveness can uncover potential anti-integrin agents.
One notable advantage of the lncRNA-ITGA2 Gene Knockout Cell Lines over existing alternatives is their specificity. Unlike traditional knockout models that may alter multiple genes, these cell lines allow for precise manipulation of the lncRNA associated with ITGA2, minimizing off-target effects and yielding more reliable results. Additionally, they are adaptable for various experimental contexts, providing versatility that makes them ideal for comprehensive studies across different research domains.
For researchers and clinicians keen to implement cutting-edge methodologies, the lncRNA-ITGA2 Gene Knockout Cell Lines represent a valuable addition to their toolkit. They are essential for advanced genetic studies, enhancing the capacity to elucidate complex biological pathways and develop novel therapeutic strategies. Our company, with extensive expertise in genetic engineering and high-quality cell line production, is dedicated to providing research products that empower scientists to push the boundaries of understanding in molecular biology. We are committed to supporting groundbreaking research with innovations that drive scientific discovery forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.